| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |